• Publications
  • Influence
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.
We evaluated 18,014 patients who underwent allogeneic bone marrow transplantation (BMT) at 235 centers worldwide to examine the incidence of and risk factors for posttransplant lymphoproliferativeExpand
  • 591
  • 30
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
BACKGROUND Although second primary cancers are a leading cause of death among men with testicular cancer, few studies have quantified risks among long-term survivors. METHODS Within 14Expand
  • 668
  • 29
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases
Soft tissue sarcomas (STS) are a heterogeneous group of uncommon tumors that show a broad range of differentiation that may reflect etiologic distinction. Routine tabulations of STS are notExpand
  • 410
  • 28
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
CONTEXT Second cancer is the leading cause of death in long-term survivors of Hodgkin disease (HD), with exceptionally high risks of breast cancer among women treated at a young age. QuantitativeExpand
  • 568
  • 27
  • PDF
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
BACKGROUND Lung cancer is a frequent cause of death in patients cured of Hodgkin's disease, but the contributions of chemotherapy, radiotherapy, and smoking are not well described. We quantified theExpand
  • 479
  • 26
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
We evaluated 26 901 patients who underwent allogeneic hematopoietic cell transplantation (HCT) at 271 centers worldwide to define patterns of posttransplantation lymphoproliferative disordersExpand
  • 302
  • 26
Solid cancers after bone marrow transplantation.
BACKGROUND The late effects of bone marrow transplantation, including cancer, need to be determined in a large population at risk. METHODS We studied 19,229 patients who received allogeneicExpand
  • 654
  • 19
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
PURPOSE Hodgkin's lymphoma (HL) survivors are known to be at substantially increased risk of solid cancers (SC). However, no investigation has used multivariate modeling to estimate the relative riskExpand
  • 284
  • 18
  • PDF
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group.
BACKGROUND Benzene is a widely distributed environmental contaminant known to cause leukemia, particularly acute nonlymphocytic leukemia, and perhaps other hematologic neoplasms and disorders. FewExpand
  • 298
  • 18
The Epidemiology of Second Primary Cancers
  • L. Travis
  • Medicine
  • Cancer Epidemiology Biomarkers & Prevention
  • 1 November 2006
Background: Due to improvements in early detection, supportive care, and treatment, the number of cancer survivors in the United States has tripled since 1971 and is growing by 2% each year. In 2001,Expand
  • 221
  • 16
  • PDF